Vicken Aharonian - Concepedia

Author

Vicken Aharonian

Also Known As

Colin Watanabe, John Conte, V Aharonian, V J Aharonian, V. Aharonian, Vicken Aharonian, Vicken J Aharonian, Vicken J. Aharonian, vicken aharonian

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Kaiser Permanente Riverside Methodist Hospital Medtronic (United States)Houston Methodist University of Pittsburgh Medical Center

About

Vicken Aharonian is an author at Kaiser Permanente specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.6K
2	Public Health	5	5	520
3	Engineering	1	1	13
4	Anesthesia	1	1	404
5	Biostatistics	1	1	24

Vicken Aharonian

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial Somjot Brar, Vicken Aharonian, Prakash Mansukhani, The Lancet AnesthesiaRenal FunctionHaemodynamic-guided Fluid AdministrationPatient SafetySepsis	2014	404
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement Michael J. Reardon, David Adams, Neal S. Kleiman, Journal of the American College of Cardiology Endovascular TechniquePatients Undergoing SurgicalVascular SurgeryOutcomes ResearchValve Disease	2015	399
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement G. Michael Deeb, Michael J. Reardon, Stan Chetcuti, Journal of the American College of Cardiology Cardiovascular DiseasePatient SafetyVascular SurgeryOutcomes ResearchValve Disease	2016	355
Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: Six-month patency rates Kwok L. Yun, YingXing Wu, Vicken Aharonian, Journal of Thoracic and Cardiovascular Surgery Six-month Patency RatesEndovascular TechniqueCardiovascular DiseaseVascular SurgeryOutcomes Research	2005	201
Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions Somjot Brar, John Kim, Simerjeet K. Brar, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseDiabetic PopulationDiabetesLong-term Outcomes	2008	113
Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors Neal S. Kleiman, Brijeshwar Maini, Michael J. Reardon, Circulation Cardiovascular Interventions	2016	98
Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less Michael J. Reardon, Neal S. Kleiman, David Adams, JAMA Cardiology	2016	72
Prevalence of Subclavian Artery Stenosis in Patients with Peripheral Vascular Disease Godofredo R. Gutierrez, Peter R. Mahrer, Vicken Aharonian, Angiology	2001	61
Discontinuation of Long-Term Clopidogrel Therapy Is Associated With Death and Myocardial Infarction After Saphenous Vein Graft Percutaneous Coronary Intervention Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseVascular SurgeryPharmacotherapy	2012	26
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial Nicolas M. Van Mieghem, Jeffrey J. Popma, G. Michael Deeb, JACC: Cardiovascular Interventions Bayesian StatisticBayesian StatisticsSurtavi TrialRandomized Controlled TrialBiostatistics	2020	24

Page 1